RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BHVN
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Wednesday for Biohaven Pharmaceutical Holding Co Ltd
(Updated on Jul 03, 2024)

Sell candidate since Jul 02, 2024 Loss -1.45% PDF

The Biohaven Pharmaceutical Holding Co Ltd stock price fell by -1.45% on the last day (Wednesday, 3rd Jul 2024) from $34.17 to $33.68. During the last trading day the stock fluctuated 4.96% from a day low at $33.44 to a day high of $35.10. The price has risen in 7 of the last 10 days and is up by 2.76% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -751 thousand shares and in total, 365 thousand shares were bought and sold for approximately $12.28 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -29.26% during the next 3 months and, with a 90% probability hold a price between $21.35 and $27.42 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BHVN Signals & Forecast

There are mixed signals in the stock today. The Biohaven Pharmaceutical Holding Co Ltd stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $34.71 and $35.19. A break-up above any of these levels will issue buy signals. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. A buy signal was issued from a pivot bottom point on Tuesday, June 18, 2024, and so far it has risen 2.76%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Biohaven Pharmaceutical Holding Co Ltd stock

Biohaven Pharmaceutical Holding Co Ltd finds support from accumulated volume at $33.56 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $1.66 (4.96%) between high and low. For the last week, the stock has had daily average volatility of 3.73%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BHVN) For The Upcoming Trading Day Of Friday 5th

For the upcoming trading day on Friday, 5th we expect Biohaven Pharmaceutical Holding Company Ltd to open at $34.07, and during the day (based on 14 day Average True Range), to move between $31.83 and $35.52, which gives a possible trading interval of +/-$1.85 (+/-5.48%) up or down from last closing price. If Biohaven Pharmaceutical Holding Company Ltd takes out the full calculated possible swing range there will be an estimated 10.96% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $33.56 (0.34%) than the resistance at $34.71 (3.07%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Biohaven Pharmaceutical Holding Company Ltd stock A Buy?

Biohaven Pharmaceutical Holding Co Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.124 Sell Candidate Unchanged

Predicted Opening Price for Biohaven Pharmaceutical Holding Company Ltd of Friday, July 5, 2024

Fair opening price July 5, 2024 Current price
$34.07 ( 1.18%) $33.68

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BHVN

Fibonacci Support & Resistance Levels

Level Price
R3 35.73 6.11%
R2 35.10 4.22%
R1 34.71 3.06%
Price 33.68
S1 33.44 -0.705%
S2 33.05 -1.87%
S3 32.41 -3.75%

Accumulated Volume Support & Resistance Levels

Level Price
R3 38.99 15.78%
R2 35.69 5.98%
R1 34.71 3.07%
Price 33.68
S1 33.56 -0.341%
S2 33.44 -0.698%
S3 33.17 -1.50%

FAQ

What is the symbol for Biohaven Pharmaceutical Holding Company Ltd Stock and on which exchange is it traded?
The symbol for Biohaven Pharmaceutical Holding Company Ltd is BHVN and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Biohaven Pharmaceutical Holding Company Ltd Stock?
Biohaven Pharmaceutical Holding Co Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Biohaven Pharmaceutical Holding Company Ltd Stock?
Biohaven Pharmaceutical Holding Company Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Biohaven Pharmaceutical Holding Company Ltd Stock.

What's the current price of Biohaven Pharmaceutical Holding Company Ltd Stock?
As of the end of day on the Jul 03, 2024, the price of an Biohaven Pharmaceutical Holding Company Ltd (BHVN) share was $33.68.

What is the 52-week high and low for Biohaven Pharmaceutical Holding Company Ltd Stock?
The 52-week high for Biohaven Pharmaceutical Holding Company Ltd Stock is $62.21 and the 52-week low is $16.45.

What is the market capitalization of Biohaven Pharmaceutical Holding Company Ltd Stock?
As of the Jul 03, 2024, the market capitalization of Biohaven Pharmaceutical Holding Company Ltd is 2.973B.

When is the next earnings date for Biohaven Pharmaceutical Holding Company Ltd?
The upcoming earnings date for Biohaven Pharmaceutical Holding Company Ltd is Jul 29, 2024.
Click to get the best stock tips daily for free!

About Biohaven Pharmaceutical Holding Company Ltd

Biohaven Pharmaceutical Holding Company Ltd Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as re... BHVN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT